jcp conference-coverage

Conference Coverage

10/17/2022

Katie Herman and Craig Ostroff

Katie Herman and Craig Ostroff ...

Michael Kolodziej, MD, Senior Advisor, ADVI, presented that patient monitoring during treatment using electronic patient-reported outcomes significantly improves results.

Michael Kolodziej, MD, Senior...

10/17/2022

Journal of Clinical Pathways

Conference Coverage

Precision Medicine and AI in Oncology Patient Care

10/16/2022

Katie Herman and Craig Ostroff

Katie Herman and Craig Ostroff ...

Tushar Pandey, CEO, SimBioSys, Inc, in his 2022 Oncology Clinical Pathways Congress presented on the value artificial intelligence brings to oncology patient care, and the need to move to guided intelligence.

Tushar Pandey, CEO, SimBioSys,...

10/16/2022

Journal of Clinical Pathways

Conference Coverage

Low-Value Care Directly Leads to Development of Cancer Genomic Pathways

10/16/2022

Katie Herman and Craig Ostroff

Katie Herman and Craig Ostroff ...

Tatjana Kolevska, MD, explains at the 2022 Oncology Clinical Pathways Conference that digital pathways are the way of the future in regard to cancer care.

Tatjana Kolevska, MD, explains...

10/16/2022

Journal of Clinical Pathways

Conference Coverage

Gene Sequencing in the Clinic

10/16/2022

Katie Herman and Craig Ostroff

Katie Herman and Craig Ostroff ...

Mahek Shah, MD, MBA, MS, at the 2022 Oncology Clinical Pathways Congress, discussed the need to enable gene sequencing-as-a-service in clinical settings and what that means for future clinical care.

Mahek Shah, MD, MBA, MS, at the...

10/16/2022

Journal of Clinical Pathways

Conference Coverage

Complex Diagnostic Imaging and the CMS Imaging AUC Program

10/16/2022

Katie Herman and Craig Ostroff

Katie Herman and Craig Ostroff ...

Elliot K Fishman, MD, FACR, Professor of Radiology, Oncology, Surgery and Urology, Johns Hopkins Hospital, presented at the 2022 Oncology Clinical Pathways Congress about Medicare’s Appropriate Use Criteria program and the challenges in...

Elliot K Fishman, MD, FACR,...

10/16/2022

Journal of Clinical Pathways

Conference Coverage

Integrating Social Determinants of Health

10/16/2022

Katie Herman and Craig Ostroff

Katie Herman and Craig Ostroff ...

At the 2022 Oncology Clinical Pathways Congress, Mishellene McKinney, MHA, RN, OCN, Vice President, Cancer Care Services, Kaiser Permanente; and Anand Shah, MD, MS, Vice President, Social Health, Kaiser Permanente, discussed the importance of...

At the 2022 Oncology Clinical...

10/16/2022

Journal of Clinical Pathways

Conference Coverage

Cancer Care Equity and Collaboration

10/16/2022

Katie Herman and Craig Ostroff

Katie Herman and Craig Ostroff ...

At the 2022 Oncology Clinical Pathways Congress, Lawrence N Shulman, MD, Abramson Cancer Center University of Pennsylvania, summarized the status of cancer care in the United States and proposed how collaborative care can enhance quality of...

At the 2022 Oncology Clinical...

10/16/2022

Journal of Clinical Pathways

Conference Coverage

Value-Based Oncology Care Solutions for Self-Insured Employers

10/15/2022

Craig Ostroff

At the 2022 Oncology Clinical Pathways Congress, Margaret Rehayem, Vice President of the National Alliance of Healthcare Purchaser Coalitions, spoke on the dramatic effect that developments in cancer care have had on employers and employees.

At the 2022 Oncology Clinical...

10/15/2022

Journal of Clinical Pathways

Conference Coverage

Optimizing Oncology Care in Older Adults

10/15/2022

Katie Herman and Craig Ostroff

Katie Herman and Craig Ostroff ...

Kjel A. Johnson, PharmD, Vice President, Specialty Product Strategy CVS Health, presented at the 2022 Oncology Clinical Pathways Congress regarding optimizing patient care in older adults from an operational and integrational perspective.

Kjel A. Johnson, PharmD, Vice...

10/15/2022

Journal of Clinical Pathways

Conference Coverage

Quality of Care and Research Initiatives in the Enhancing Oncology Model

10/15/2022

Katie Herman and Craig Ostroff

Katie Herman and Craig Ostroff ...

Lee A. Fleisher, MD, CMS Chief Medical Officer, Director, Center for Clinical Standards and Quality, presented data at the 2022 Oncology Clinical Pathways Congress regarding the Oncology Care Model as well as the development plan for the...

Lee A. Fleisher, MD, CMS Chief...

10/15/2022

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Conference Coverage

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products